A detailed history of Covestor LTD transactions in Ardelyx, Inc. stock. As of the latest transaction made, Covestor LTD holds 2,924 shares of ARDX stock, worth $16,345. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,924
Previous 2,033 43.83%
Holding current value
$16,345
Previous $15,000 33.33%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$5.28 - $7.57 $4,704 - $6,744
891 Added 43.83%
2,924 $20,000
Q2 2024

Aug 09, 2024

SELL
$5.89 - $9.31 $2,055 - $3,249
-349 Reduced 14.65%
2,033 $15,000
Q1 2024

May 10, 2024

SELL
$6.05 - $9.74 $39,984 - $64,371
-6,609 Reduced 73.51%
2,382 $17,000
Q4 2023

Feb 09, 2024

SELL
$3.29 - $6.64 $4,563 - $9,209
-1,387 Reduced 13.36%
8,991 $56,000
Q3 2023

Nov 13, 2023

SELL
$3.3 - $4.83 $5,266 - $7,708
-1,596 Reduced 13.33%
10,378 $42,000
Q2 2023

Aug 11, 2023

BUY
$3.23 - $4.95 $5,985 - $9,172
1,853 Added 18.31%
11,974 $41,000
Q1 2023

May 15, 2023

SELL
$2.68 - $4.79 $21,158 - $37,817
-7,895 Reduced 43.82%
10,121 $48,000
Q4 2022

Feb 13, 2023

BUY
$1.22 - $2.85 $21,979 - $51,345
18,016 New
18,016 $51,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $864M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.